Stabvida - stabvida.com
General Information:
Latest News:
Malaria Genomes Pose New Challenges 6 Aug 2012 | 09:41 pm
Malaria Genomes Pose New Challenges
GSK closes 36B buyout of HGS 6 Aug 2012 | 09:18 pm
GlaxoSmithKline finalized its purchase of Human Genome Sciences for $3.6 billion, after several months of negotiations. -More-
Sanofi-Regenerons Zaltrap gets FDA OK for colon cancer 6 Aug 2012 | 09:18 pm
Sanofi and Regeneron Pharmaceuticals' Zaltrap, or aflibercept, secured FDA approval as a treatment for metastatic colorectal -More-
Presidential commission readies genomic privacy recommendations 6 Aug 2012 | 09:18 pm
The Presidential Commission for the Study of Bioethical Issues is close to completing a set of recommendations designed to ad -More-
Monsantos biotech corn gets sales nod from Wal-Mart 6 Aug 2012 | 09:18 pm
Wal-Mart Stores has confirmed it is open to selling Monsanto's herbicide-resistant and pest-resistant biotech sweet corn. -More-
FDA to review Medivation-Astellas prostate cancer drug in November 6 Aug 2012 | 09:18 pm
The FDA is set to evaluate MDV3100, or enzalutamide, an investigational prostate cancer drug from Medivation and Astellas Pha -More-
Ziopharm obtains US patent for cancer treatment 6 Aug 2012 | 09:18 pm
The U.S. -More-
Biotech startup obtains 2 million in first funding round 6 Aug 2012 | 09:18 pm
New biotech firm eXIthera Pharmaceuticals secured $2 million in its Series A financing round. -More-
Gilead and 3 Indian firms partner on generics of HIV drug Emtriva 6 Aug 2012 | 09:18 pm
Gilead Sciences is collaborating with Strides Arcolab, Ranbaxy Laboratories and Mylan's Indian arm to increase sales and cut -More-
BIO joins in creation of group to defend renewable fuel standard 6 Aug 2012 | 09:18 pm
BIO and seven other biofuel groups have established the Biofuels Producers Coordinating Council to fight efforts to weaken or -More-
